888-899-6266        info@BioCoreUSA.com   
0 item(s) $0.00 
 
TISSUE ARRAYS
 
OV962Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores
Cores96Cases48
Row number8Column number12
Core Diameter(mm)1.5Thickness(µm)5.0
Tissue Array TypeFFPESpeciesHuman
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Product name:OV962
 
Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores
 
Price: $150.00
 
PLEASE SELECT TYPE
 
Qty:
 
To Check Overlapping Cases
 
 
Legend:
Ova
-Ovary
 
Malignant (*)
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Metastasis (*)
 
NAT (*)
TISSUE  ARRAYS OV962
1
2
3
4
5
6
7
8
9
10
11
12
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageType
A1137FOvarySerous papillary adenocarcinoma1T1cN0M0ICMalignant
A2256FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
A3337FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
A4455FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
A5539FOvarySerous papillary adenocarcinoma3T1N0M0IMalignant
A6653FOvarySerous papillary adenocarcinoma3T1N0M0IMalignant
A7754FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
A8860FOvaryAdenocarcinoma (sparse)*T1bN0M0IBMalignant
A9950FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
A101052FOvarySerous adenocarcinoma3T1aN0M0IAMalignant
A111163FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignant
A121246FOvarySerous adenocarcinoma3T1N0M0IMalignant
B11337FOvarySerous papillary adenocarcinoma1T1cN0M0ICMalignant
B21456FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
B31537FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
B41655FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
B51739FOvarySerous papillary adenocarcinoma3T1N0M0IMalignant
B61853FOvarySerous papillary adenocarcinoma3T1N0M0IMalignant
B71954FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
B82060FOvarySerous adenocarcinoma3T1bN0M0IBMalignant
B92150FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
B102252FOvarySerous adenocarcinoma3T1aN0M0IAMalignant
B112363FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignant
B122446FOvarySerous adenocarcinoma3T1N0M0IMalignant
C12542FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
C22646FOvaryMucinous papillary adenocarcinoma2T1N0M0IMalignant
C32754FOvaryMucinous papillary adenocarcinoma2T1bN0M0IBMalignant
C42839FOvaryMucinous papillary adenocarcinoma2T1bN0M0IBMalignant
C52949FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignant
C63064FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignant
C73167FOvaryMucinous papillary adenocarcinoma2T1N0M0IMalignant
C83237FOvaryMucinous papillary adenocarcinoma2--3T1N0M0IMalignant
C93340FOvaryMucinous papillary adenocarcinoma2--3T1cN0M0ICMalignant
C103465FOvaryEndometrioid adenocarcinoma1T1cN0M0ICMalignant
C113554FOvaryEndometrioid adenocarcinoma1T1bN0M0IBMalignant
C123640FOvaryEndometrioid adenocarcinoma2T1aN0M0IAMalignant
D13742FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
D23846FOvaryMucinous papillary adenocarcinoma2T1N0M0IMalignant
D33954FOvaryMucinous papillary adenocarcinoma2T1bN0M0IBMalignant
D44039FOvaryMucinous papillary adenocarcinoma2T1bN0M0IBMalignant
D54149FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignant
D64264FOvaryMucinous papillary adenocarcinoma2T1aN0M0IAMalignant
D74367FOvaryMucinous papillary adenocarcinoma2T1N0M0IMalignant
D84437FOvaryMucinous papillary adenocarcinoma2--3T1N0M0IMalignant
D94540FOvaryMucinous papillary adenocarcinoma2--3T1cN0M0ICMalignant
D104665FOvaryEndometrioid adenocarcinoma with necrosis (sparse)1T1cN0M0ICMalignant
D114754FOvaryEndometrioid adenocarcinoma1T1bN0M0IBMalignant
D124840FOvaryEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant
E14969FOvaryEndometrioid adenocarcinoma1T1aN0M0IAMalignant
E25049FOvaryEndometrioid adenocarcinoma2T1N0M0IMalignant
E35143FOvaryEndometrioid adenocarcinoma2T1cN0M0ICMalignant
E45262FOvaryEndometrioid adenocarcinoma3T1aN0M0IAMalignant
E55364FOvaryEndometrioid adenocarcinoma3T1aN0M0IAMalignant
E65445FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant
E75555FOvaryEndometrioid adenocarcinoma1T1aN0M0IAMalignant
E85675FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant
E95733FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant
E105824FOvaryUndifferentiated carcinoma*T1aN0M0IAMalignant
E115918FOvaryDisgerminoma*T1aN0M0IAMalignant
E126049FOvaryDisgerminoma*T1bN0M0IBMalignant
F16169FOvaryEndometrioid adenocarcinoma1T1aN0M0IAMalignant
F26249FOvaryEndometrioid adenocarcinoma2T1N0M0IMalignant
F36343FOvaryEndometrioid adenocarcinoma2T1cN0M0ICMalignant
F46462FOvaryEndometrioid adenocarcinoma3T1aN0M0IAMalignant
F56564FOvaryEndometrioid adenocarcinoma3T1aN0M0IAMalignant
F66645FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant
F76755FOvaryEndometrioid adenocarcinoma1T1aN0M0IAMalignant
F86875FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant
F96933FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant
F107024FOvaryUndifferentiated carcinoma (sparse)*T1aN0M0IAMalignant
F117118FOvaryDisgerminoma*T1aN0M0IAMalignant
F127249FOvaryDisgerminoma*T1bN0M0IBMalignant
G17325FOvaryEndodermal sinus carcinoma (sparse)*T1bN0M0IBMalignant
G27415FOvaryEndodermal sinus carcinoma*T1bN0M0IBMalignant
G37538FOvaryKrukenberg tumor***Metastasis
G47642FOvaryGranular cell tumor***Malignant
G57757FOvaryGranular cell tumor***Malignant
G67847FOvaryTheca cell tumor***Malignant
G77962FOvaryTheca cell tumor***Malignant
G88062FOvaryTheca cell tumor***Malignant
G98170FOvaryTheca cell tumor***Malignant
G108265FOvaryTheca cell tumor***Malignant
G118333FOvaryAdjacent normal ovary tissue***NAT
G128442FOvaryAdjacent normal ovary tissue***NAT
H18525FOvaryEndodermal sinus carcinoma (sparse)*T1bN0M0IBMalignant
H28615FOvaryEndodermal sinus carcinoma*T1bN0M0IBMalignant
H38738FOvaryKrukenberg tumor***Metastasis
H48842FOvaryGranular cell tumor***Malignant
H58957FOvaryGranular cell tumor***Malignant
H69047FOvaryTheca cell tumor***Malignant
H79162FOvaryTheca cell tumor***Malignant
H89262FOvaryTheca cell tumor***Malignant
H99370FOvaryTheca cell tumor***Malignant
H109465FOvaryTheca cell tumor***Malignant
H119533FOvaryAdjacent normal ovary tissue***NAT
H129642FOvaryAdjacent normal ovary tissue***NAT
Tissue Marker
 
 
BioCoreUSA Corporation
6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States
 
CONTACT US
Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266
SUPPORT
Delivery
Privacy Policy
Terms & Conditions
FAQs